NURO NeuroMetrix Inc

Price (delayed)

$3.63

Market cap

$13.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.42

Enterprise value

$9.6M

Highlights
NURO's quick ratio has surged by 130% year-on-year and by 11% since the previous quarter
The equity has surged by 109% year-on-year
NURO's revenue is down by 12% year-on-year

Key stats

What are the main financial stats of NURO
Market
Shares outstanding
3.8M
Market cap
$13.81M
Enterprise value
$9.6M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.62
Price to sales (P/S)
1.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.3
Earnings
Revenue
$7.36M
EBIT
-$1.49M
EBITDA
-$1.41M
Free cash flow
-$1.35M
Per share
EPS
-$0.42
Free cash flow per share
-$0.36
Book value per share
$1.39
Revenue per share
$1.94
TBVPS
$2.03
Balance sheet
Total assets
$7.72M
Total liabilities
$2.46M
Debt
$938,083
Equity
$5.26M
Working capital
$4.88M
Liquidity
Debt to equity
0.18
Current ratio
3.34
Quick ratio
2.69
Net debt/EBITDA
2.99
Margins
EBITDA margin
-19.1%
Gross margin
71.7%
Net margin
-20.3%
Operating margin
-20.3%
Efficiency
Return on assets
-18.3%
Return on equity
-28%
Return on invested capital
-82.8%
Return on capital employed
-26.5%
Return on sales
-20.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NURO stock price

How has the NeuroMetrix stock price performed over time
Intraday
-4.47%
1 week
9.67%
1 month
21%
1 year
100.55%
YTD
14.87%
QTD
6.45%

Financial performance

How have NeuroMetrix's revenue and profit performed over time
Revenue
$7.36M
Gross profit
$5.28M
Operating income
-$1.5M
Net income
-$1.49M
Gross margin
71.7%
Net margin
-20.3%
NURO's gross margin has surged by 99% year-on-year
NURO's operating income has surged by 82% year-on-year and by 29% since the previous quarter
NURO's operating margin has soared by 80% YoY and by 29% QoQ
NURO's net income has soared by 77% YoY and by 29% QoQ

Growth

What is NeuroMetrix's growth rate over time

Valuation

What is NeuroMetrix stock price valuation
P/E
N/A
P/B
2.62
P/S
1.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.3
NURO's EPS has soared by 93% YoY and by 39% QoQ
The P/B is 138% above the 5-year quarterly average of 1.1 and 54% above the last 4 quarters average of 1.7
The equity has surged by 109% year-on-year
The stock's price to sales (P/S) is 44% more than its last 4 quarters average of 1.3
NURO's revenue is down by 12% year-on-year

Efficiency

How efficient is NeuroMetrix business performance
NeuroMetrix's ROE has soared by 85% YoY and by 38% from the previous quarter
NURO's ROA has soared by 77% YoY and by 32% from the previous quarter
The ROIC has soared by 74% YoY and by 24% from the previous quarter
NURO's ROS has soared by 74% YoY and by 29% QoQ

Dividends

What is NURO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NURO.

Financial health

How did NeuroMetrix financials performed over time
NURO's quick ratio has surged by 130% year-on-year and by 11% since the previous quarter
The current ratio has soared by 98% YoY and by 8% from the previous quarter
NeuroMetrix's debt is 82% lower than its equity
The equity has surged by 109% year-on-year
NURO's debt to equity has dropped by 68% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.